BofA upgrades Texas Instruments stock rating on industrial strength By Investing.com

BofA Securities upgraded Texas Instruments to Buy from Neutral and lifted its price target to $320 from $235 after Q1 results and Q2 guidance increased confidence in an industrial recovery and data-center demand. BofA raised 2026, 2027, and 2028 GAAP EPS estimates by 21%, 31%, and 33% to $7.52, $9.35, and $10.75, respectively, implying a 26% CAGR in EPS from 2025 to 2028. The stock trades at $236.31, near its 52-week high of $238.80, and at 43.15x P/E.

Analysis

This is less a one-day sentiment pop and more a re-rating of TXN’s terminal earnings power. The market has been treating analog as a slow-growth, mature cash generator; what changes here is the evidence that industrial cyclical demand is not just normalizing but broadening into higher-value end markets, which can support both utilization and mix for longer than consensus expects. The second-order effect is that domestic-capacity analog names with hard-to-replicate fab footprints should see a valuation premium persist as customers prioritize supply assurance over incremental unit cost savings.

The key debate is not whether earnings are improving over the next few quarters, but whether the street is overpaying for a cyclical upturn that may look more durable than it really is. TXN already trades like a quality compounder, so the next leg requires either continued estimate revisions or evidence that margin expansion can outpace capex drag and pricing normalization. If industrial and defense demand stays firm, the company can convert the current cycle into a multi-year free-cash-flow story; if not, the multiple is vulnerable because the stock is already discounting a lot of 2027-2028 strength.

A subtle winner here is the domestic semiconductor supply chain: foundry-capacity scarcity and U.S. fab investment should improve negotiating leverage for companies that can commit long-duration demand, while pressuring smaller competitors that lack scale or domestic manufacturing. The biggest near-term risk is that investors extrapolate data-center growth too far; that segment can be lumpy and capacity-constrained, so any digestion phase would hit sentiment quickly even if core industrial demand holds. The contrarian view is that the upgrade may be late-stage confirmation rather than fresh alpha — when multiple expansion is already embedded, the better trade may be relative value rather than outright chasing the name.

Key Decisions for Investors

• Stay long TXN, but express it as a 3-6 month momentum/quality hold rather than a fresh deep-value entry; upside is continued estimate revisions, while downside is multiple compression if growth normalizes.
• Consider a pair trade: long TXN / short a lower-quality cyclical semiconductor peer with less domestic fab leverage over the next 1-2 quarters; the thesis is TXN earns a scarcity premium while weaker names give back on any demand hiccup.
• Use call spreads instead of outright stock if initiating here: the stock is near highs and already rich on forward earnings, so capped-risk upside participation is preferable to paying full premium for incremental re-rating.
• Set a tactical trim level if there is a post-upgrade gap higher: if the stock extends another 5-8% without new fundamental evidence, reduce exposure into strength because the market may have already discounted the next two estimate beats.
• Watch industrial order commentary and any data-center revenue deceleration over the next 1-2 earnings prints; those are the fastest signals that the thesis is being pulled forward faster than fundamentals can support.